Vulnerability · CVE-2026-34177
Canonical LXD versions 4.12 through 6.7 contain an incomplete denylist in isVMLowLevelOptionForbidden (lxd/project/limits/permissions.go), which omits raw.apparmor and…
Published Apr 9, 2026 · catalog updated Jun 17, 2026 · the affected product
Check if you run it
No confirmed exploitation is on record for CVE-2026-34177. EPSS is 0.61%. Act only if a listed version of the affected product is installed.
Gaps on this record
- No plain product name is stored. The page cannot tell you which product to check.
- No version range is stored. A customer cannot check an installed version against this record.
- No vendor fix or required action is stored. Compare the linked advisory before you change production.
- Severity
- Critical9.1
- Known exploitation
- Not in CISA/VulnCheck KEV
- EPSS
- 0.61%
- Remediation
- Advisory link
- Affected products
- cpe canonical/lxd
Canonical LXD versions 4.12 through 6.7 contain an incomplete denylist in isVMLowLevelOptionForbidden (lxd/project/limits/permissions.go), which omits raw.apparmor and raw.qemu.conf from the set of keys blocked under the restricted.virtual-machines.lowlevel=block project restriction. A remote attacker with can_edit permission on a VM instance in a restricted project can inject an AppArmor rule and a QEMU chardev configuration that bridges the LXD Unix socket into the guest VM, enabling privilege escalation to LXD cluster administrator and subsequently to host root.
Are you affected?
Enter the version you run. The result uses only the ranges stored on this record.
The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.
- cpe canonical/lxdversion unspecified
How to fix CVE-2026-34177
Recommended remediation
A patch or advisory reference is linked. Open the original publisher for availability by product version.
Official advisories
What to do
Three questions, each answered from this record only. Confirm the vendor advisory before you patch.
Should you patch?
No confirmed exploitation is on record for CVE-2026-34177. EPSS is 0.61%. Act only if a listed version of the affected product is installed.
Which versions are affected?
Affected version ranges are not on this record. Compare the installed version with the linked vendor advisory before you change production.
What should an analyst verify?
CWE-184. EPSS 0.61%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.
Technology hubs
Code
The project this record applies to. Exploit listings stay in References.
Timeline
Detection, updates, and resolution for this record.
Apr 9, 2026 · NIST NVD
Detected
Canonical LXD versions 4.12 through 6.7 contain an incomplete denylist in isVMLowLevelOptionForbidden (lxd/project/limits/permissions.go), which omits raw.apparmor and raw.qemu.conf from the set of keys blocked under the restricted.virtual-machines.lowlevel=block project restriction. A remote attacker with can_edit permission on a VM instance in a restricted project can inject an AppArmor rule and
Jun 17, 2026 · NIST NVD
Updated
Canonical LXD versions 4.12 through 6.7 contain an incomplete denylist in isVMLowLevelOptionForbidden (lxd/project/limits/permissions.go), which omits raw.apparmor and raw.qemu.conf from the set of keys blocked under the restricted.virtual-machines.lowlevel=block project restriction. A remote attacker with can_edit permission on a VM instance in a restricted project can inject an AppArmor rule and
Sources
- CVE.orgVulnerability recordCVE-2026-34177
Official CVE identifier
cve.org - FIRST EPSSExploitation probabilityCVE-2026-34177
30-day exploitation probability 0.6%
first.org - NIST NVDVulnerability recordCVE-2026-34177
Canonical LXD versions 4.12 through 6.7 contain an incomplete denylist in isVMLowLevelOptionForbidden (lxd/project/limits/permissions.go), which omits raw.apparmor and raw.qemu.conf from the set of keys blocked under the restricted.virtual-machines.lowlevel=block project restrict
nvd.nist.gov
References
Freshness
Last verified in this catalog Oct 18, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.